APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Analysis and Forecast 2026-2032

19 December 2025209 pages

Choose your research edition.

Industry ResearchTetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) include Whistler, The Lab, Select Oil, Pharmahemp, NuLeaf Naturals, Medical Marijuana, Kazmira, K.I.N.D. Concentrates and HempLife Today, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), also provides the sales of main regions and countries. Of the upcoming market potential for Tetrahydrocannabinol (THC) and Cannabidiol (CBD), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tetrahydrocannabinol (THC) and Cannabidiol (CBD) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) sales, projected growth trends, production technology, application and end-user industry.

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Company

Whistler

The Lab

Select Oil

Pharmahemp

NuLeaf Naturals

Medical Marijuana

Kazmira

K.I.N.D. Concentrates

HempLife Today

Green Road

Freedom Leaf

Folium Biosciences

ENDOCA

Emblem Cannabis Oils

CW Hemp/CW Botanicals

CBD American Shaman

Canopy Growth Corporation

Cannavest

Aphria

Absolute Terps

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tetrahydrocannabinol (THC) and Cannabidiol (CBD) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tetrahydrocannabinol (THC) Major Manufacturers Table 3. Cannabidiol (CBD) Major Manufacturers Table 4. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceuticals Industry Major Manufacturers Table 6. Food Industry Major Manufacturers Table 7. Cosmetics Industry Major Manufacturers Table 8. Other Major Manufacturers Table 9. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends Table 10. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers Table 11. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges Table 12. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2026) Table 17. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2027-2032) Table 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (Tons) Table 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032) & (Tons) Table 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2026) Table 22. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2027-2032) Table 23. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Manufacturers (2021-2026) Table 27. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers, Product Type & Application Table 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2026) Table 38. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2027-2032) Table 39. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 40. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 41. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 42. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2026) Table 43. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2027-2032) Table 44. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2026) & (US$/Ton) Table 45. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2027-2032) & (US$/Ton) Table 46. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2026) Table 50. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2027-2032) Table 51. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 52. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 53. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 54. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2026) Table 55. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2027-2032) Table 56. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2026) & (US$/Ton) Table 57. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2027-2032) & (US$/Ton) Table 58. Whistler Company Information Table 59. Whistler Business Overview Table 60. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 62. Whistler Recent Development Table 63. The Lab Company Information Table 64. The Lab Business Overview Table 65. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 67. The Lab Recent Development Table 68. Select Oil Company Information Table 69. Select Oil Business Overview Table 70. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 72. Select Oil Recent Development Table 73. Pharmahemp Company Information Table 74. Pharmahemp Business Overview Table 75. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 77. Pharmahemp Recent Development Table 78. NuLeaf Naturals Company Information Table 79. NuLeaf Naturals Business Overview Table 80. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 82. NuLeaf Naturals Recent Development Table 83. Medical Marijuana Company Information Table 84. Medical Marijuana Business Overview Table 85. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 87. Medical Marijuana Recent Development Table 88. Kazmira Company Information Table 89. Kazmira Business Overview Table 90. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 92. Kazmira Recent Development Table 93. K.I.N.D. Concentrates Company Information Table 94. K.I.N.D. Concentrates Business Overview Table 95. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 97. K.I.N.D. Concentrates Recent Development Table 98. HempLife Today Company Information Table 99. HempLife Today Business Overview Table 100. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 102. HempLife Today Recent Development Table 103. Green Road Company Information Table 104. Green Road Business Overview Table 105. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 107. Green Road Recent Development Table 108. Freedom Leaf Company Information Table 109. Freedom Leaf Business Overview Table 110. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 112. Freedom Leaf Recent Development Table 113. Folium Biosciences Company Information Table 114. Folium Biosciences Business Overview Table 115. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 117. Folium Biosciences Recent Development Table 118. ENDOCA Company Information Table 119. ENDOCA Business Overview Table 120. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 122. ENDOCA Recent Development Table 123. Emblem Cannabis Oils Company Information Table 124. Emblem Cannabis Oils Business Overview Table 125. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 127. Emblem Cannabis Oils Recent Development Table 128. CW Hemp/CW Botanicals Company Information Table 129. CW Hemp/CW Botanicals Business Overview Table 130. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 132. CW Hemp/CW Botanicals Recent Development Table 133. CBD American Shaman Company Information Table 134. CBD American Shaman Business Overview Table 135. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 137. CBD American Shaman Recent Development Table 138. Canopy Growth Corporation Company Information Table 139. Canopy Growth Corporation Business Overview Table 140. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 142. Canopy Growth Corporation Recent Development Table 143. Cannavest Company Information Table 144. Cannavest Business Overview Table 145. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 147. Cannavest Recent Development Table 148. Aphria Company Information Table 149. Aphria Business Overview Table 150. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 151. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 152. Aphria Recent Development Table 153. Absolute Terps Company Information Table 154. Absolute Terps Business Overview Table 155. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 156. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 157. Absolute Terps Recent Development Table 158. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 161. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 162. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2021-2026) & (US$/Ton) Table 163. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2027-2032) & (US$/Ton) Table 164. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 167. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 168. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2021-2026) & (US$/Ton) Table 169. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2027-2032) & (US$/Ton) Table 170. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 174. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 175. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 176. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2021-2026) & (US$/Ton) Table 177. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2027-2032) & (US$/Ton) Table 178. United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 179. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 180. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 183. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 184. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2021-2026) & (US$/Ton) Table 185. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2027-2032) & (US$/Ton) Table 186. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 189. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 190. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2021-2026) & (US$/Ton) Table 191. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2027-2032) & (US$/Ton) Table 192. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 196. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 197. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 198. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2021-2026) & (US$/Ton) Table 199. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2027-2032) & (US$/Ton) Table 200. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 201. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 202. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 203. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 204. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 205. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 206. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 207. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 208. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 209. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2021-2026) & (US$/Ton) Table 210. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2027-2032) & (US$/Ton) Table 211. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 212. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 213. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 214. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 215. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2021-2026) & (US$/Ton) Table 216. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2027-2032) & (US$/Ton) Table 217. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 218. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 219. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 220. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 221. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2021-2026) & (US$/Ton) Table 222. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2027-2032) & (US$/Ton) Table 223. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 224. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 225. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 226. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 227. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2021-2026) & (US$/Ton) Table 228. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2027-2032) & (US$/Ton) Table 229. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 233. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 234. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 235. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2021-2026) & (US$/Ton) Table 236. Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2027-2032) & (US$/Ton) Table 237. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 238. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 239. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 240. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 241. China Taiwan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 242. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 243. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 244. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 245. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 246. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 247. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2021-2026) & (US$/Ton) Table 248. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Type (2027-2032) & (US$/Ton) Table 249. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 250. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 251. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 252. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 253. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2021-2026) & (US$/Ton) Table 254. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Application (2027-2032) & (US$/Ton) Table 255. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 256. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 257. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 258. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 259. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 260. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 261. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2021-2026) & (US$/Ton) Table 262. SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Country (2027-2032) & (US$/Ton) Table 263. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 264. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 265. Chile Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 266. Colombia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 267. Peru Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 268. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 269. Israel Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 270. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 271. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 272. Iran Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 273. Egypt Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Table 274. Key Raw Materials Table 275. Raw Materials Key Suppliers Table 276. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List Table 277. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers List Table 278. Research Programs/Design for This Report Table 279. Authors List of This Report Table 280. Secondary Sources Table 281. Primary Sources List of Figures Figure 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Image Figure 2. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tetrahydrocannabinol (THC) Image Figure 5. Cannabidiol (CBD) Image Figure 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceuticals Industry Image Figure 9. Food Industry Image Figure 10. Cosmetics Industry Image Figure 11. Other Image Figure 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2032) & (US$ Million) Figure 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2032) Figure 17. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032) & (Tons) Figure 18. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales YoY (2021-2032) & (Tons) Figure 21. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales YoY (2021-2032) & (Tons) Figure 22. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales YoY (2021-2032) & (Tons) Figure 23. Asia (Excluding China) Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales YoY (2021-2032) & (Tons) Figure 24. South America, Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales YoY (2021-2032) & (Tons) Figure 25. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032) Figure 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032) Figure 34. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032) Figure 37. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 38. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032) Figure 40. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Type (2021-2032) Figure 41. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Type (2021-2032) Figure 42. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Application (2021-2032)

Scope & coverage.

Types
  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Whistler
  • The Lab
  • Select Oil
  • Pharmahemp
  • NuLeaf Naturals
  • Medical Marijuana
  • Kazmira
  • K.I.N.D. Concentrates
  • HempLife Today
  • Green Road
  • Freedom Leaf
  • Folium Biosciences
  • ENDOCA
  • Emblem Cannabis Oils
  • CW Hemp/CW Botanicals
  • CBD American Shaman
  • Canopy Growth Corporation
  • Cannavest
  • Aphria
  • Absolute Terps

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Type
  3. 1.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tetrahydrocannabinol (THC)
  5. 1.2.3 Cannabidiol (CBD)
  6. 1.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Application
  7. 1.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceuticals Industry
  9. 1.3.3 Food Industry
  10. 1.3.4 Cosmetics Industry
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Dynamics
  1. 2.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  2. 2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers
  3. 2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region
  3. 3.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2021-2026)
  5. 3.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2027-2032)
  6. 3.2.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region
  9. 3.4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026)
  11. 3.4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032)
  12. 3.4.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Manufacturers
  2. 4.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Manufacturers
  6. 4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers, Product Type & Application
  13. 4.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market CR5 and HHI
  16. 4.8.2 2025 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Tier 1, Tier 2, and Tier 3
5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Type
  1. 5.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type
  2. 5.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type
  6. 5.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type
6 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Application
  1. 6.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application
  2. 6.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application
  6. 6.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application
7 Company Profiles
  1. 7.1 Whistler
  2. 7.1.1 Whistler Company Information
  3. 7.1.2 Whistler Business Overview
  4. 7.1.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  6. 7.1.5 Whistler Recent Developments
  7. 7.2 The Lab
  8. 7.2.1 The Lab Company Information
  9. 7.2.2 The Lab Business Overview
  10. 7.2.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  12. 7.2.5 The Lab Recent Developments
  13. 7.3 Select Oil
  14. 7.3.1 Select Oil Company Information
  15. 7.3.2 Select Oil Business Overview
  16. 7.3.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  18. 7.3.5 Select Oil Recent Developments
  19. 7.4 Pharmahemp
  20. 7.4.1 Pharmahemp Company Information
  21. 7.4.2 Pharmahemp Business Overview
  22. 7.4.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  24. 7.4.5 Pharmahemp Recent Developments
  25. 7.5 NuLeaf Naturals
  26. 7.5.1 NuLeaf Naturals Company Information
  27. 7.5.2 NuLeaf Naturals Business Overview
  28. 7.5.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  30. 7.5.5 NuLeaf Naturals Recent Developments
  31. 7.6 Medical Marijuana
  32. 7.6.1 Medical Marijuana Company Information
  33. 7.6.2 Medical Marijuana Business Overview
  34. 7.6.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  36. 7.6.5 Medical Marijuana Recent Developments
  37. 7.7 Kazmira
  38. 7.7.1 Kazmira Company Information
  39. 7.7.2 Kazmira Business Overview
  40. 7.7.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  42. 7.7.5 Kazmira Recent Developments
  43. 7.8 K.I.N.D. Concentrates
  44. 7.8.1 K.I.N.D. Concentrates Company Information
  45. 7.8.2 K.I.N.D. Concentrates Business Overview
  46. 7.8.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  48. 7.8.5 K.I.N.D. Concentrates Recent Developments
  49. 7.9 HempLife Today
  50. 7.9.1 HempLife Today Company Information
  51. 7.9.2 HempLife Today Business Overview
  52. 7.9.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  54. 7.9.5 HempLife Today Recent Developments
  55. 7.10 Green Road
  56. 7.10.1 Green Road Company Information
  57. 7.10.2 Green Road Business Overview
  58. 7.10.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  60. 7.10.5 Green Road Recent Developments
  61. 7.11 Freedom Leaf
  62. 7.11.1 Freedom Leaf Company Information
  63. 7.11.2 Freedom Leaf Business Overview
  64. 7.11.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  66. 7.11.5 Freedom Leaf Recent Developments
  67. 7.12 Folium Biosciences
  68. 7.12.1 Folium Biosciences Company Information
  69. 7.12.2 Folium Biosciences Business Overview
  70. 7.12.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  72. 7.12.5 Folium Biosciences Recent Developments
  73. 7.13 ENDOCA
  74. 7.13.1 ENDOCA Company Information
  75. 7.13.2 ENDOCA Business Overview
  76. 7.13.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  78. 7.13.5 ENDOCA Recent Developments
  79. 7.14 Emblem Cannabis Oils
  80. 7.14.1 Emblem Cannabis Oils Company Information
  81. 7.14.2 Emblem Cannabis Oils Business Overview
  82. 7.14.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  84. 7.14.5 Emblem Cannabis Oils Recent Developments
  85. 7.15 CW Hemp/CW Botanicals
  86. 7.15.1 CW Hemp/CW Botanicals Company Information
  87. 7.15.2 CW Hemp/CW Botanicals Business Overview
  88. 7.15.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  90. 7.15.5 CW Hemp/CW Botanicals Recent Developments
  91. 7.16 CBD American Shaman
  92. 7.16.1 CBD American Shaman Company Information
  93. 7.16.2 CBD American Shaman Business Overview
  94. 7.16.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  96. 7.16.5 CBD American Shaman Recent Developments
  97. 7.17 Canopy Growth Corporation
  98. 7.17.1 Canopy Growth Corporation Company Information
  99. 7.17.2 Canopy Growth Corporation Business Overview
  100. 7.17.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  102. 7.17.5 Canopy Growth Corporation Recent Developments
  103. 7.18 Cannavest
  104. 7.18.1 Cannavest Company Information
  105. 7.18.2 Cannavest Business Overview
  106. 7.18.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  108. 7.18.5 Cannavest Recent Developments
  109. 7.19 Aphria
  110. 7.19.1 Aphria Company Information
  111. 7.19.2 Aphria Business Overview
  112. 7.19.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  114. 7.19.5 Aphria Recent Developments
  115. 7.20 Absolute Terps
  116. 7.20.1 Absolute Terps Company Information
  117. 7.20.2 Absolute Terps Business Overview
  118. 7.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  120. 7.20.5 Absolute Terps Recent Developments
8 North America
  1. 8.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  2. 8.1.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  3. 8.1.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  4. 8.1.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
  5. 8.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  6. 8.2.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  7. 8.2.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  8. 8.2.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
  9. 8.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  10. 8.3.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  2. 9.1.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  4. 9.1.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
  5. 9.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  6. 9.2.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  8. 9.2.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
  9. 9.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  10. 9.3.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  2. 10.1.1 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  3. 10.1.2 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  4. 10.1.3 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
  5. 10.2 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  6. 10.2.1 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  7. 10.2.2 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  8. 10.2.3 China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  2. 11.1.1 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  4. 11.1.3 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
  5. 11.2 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  6. 11.2.1 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  8. 11.2.3 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
  9. 11.3 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  10. 11.3.1 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  2. 12.1.1 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
  5. 12.2 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  6. 12.2.1 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
  9. 12.3 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  10. 12.3.1 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Analysis
  2. 13.1.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process
  6. 13.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
  9. 13.2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst